Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.

<h4>Background</h4>Systemic sclerosis (SSc) is an autoimmune disease characterized by immunological and vascular abnormalities. Until now, the cause of SSc remains unclear. Sclerodermatous graft-versus-host disease (ScGVHD) is one of the most severe complications following bone marrow tr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cinzia Scambi, Valentina La Verde, Lucia De Franceschi, Giovanni Barausse, Fabio Poli, Fabio Benedetti, Marco Sorio, Francesca Deriu, Paola Roncada, Oscar Bortolami, Francesco Turrini, Paola Caramaschi, Chiara Stranieri, Lisa M Bambara, Domenico Biasi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0f29c7cea65a4325a1a0a80bc85bd6ec
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0f29c7cea65a4325a1a0a80bc85bd6ec
record_format dspace
spelling oai:doaj.org-article:0f29c7cea65a4325a1a0a80bc85bd6ec2021-11-18T06:36:07ZComparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.1932-620310.1371/journal.pone.0012162https://doaj.org/article/0f29c7cea65a4325a1a0a80bc85bd6ec2010-08-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20730046/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Systemic sclerosis (SSc) is an autoimmune disease characterized by immunological and vascular abnormalities. Until now, the cause of SSc remains unclear. Sclerodermatous graft-versus-host disease (ScGVHD) is one of the most severe complications following bone marrow transplantation (BMT) for haematological disorders. Since the first cases, the similarity of ScGVHD to SSc has been reported. However, both diseases could have different etiopathogeneses. The objective of this study was to identify new serum biomarkers involved in SSc and ScGVHD.<h4>Methodology</h4>Serum was obtained from patients with SSc and ScGVHD, patients without ScGVHD who received BMT for haematological disorders and healthy controls. Bi-dimensional electrophoresis (2D) was carried out to generate maps of serum proteins from patients and controls. The 2D maps underwent image analysis and differently expressed proteins were identified. Immuno-blot analysis and ELISA assay were used to validate the proteomic data. Hemolytic assay with sheep erythrocytes was performed to evaluate the capacity of Factor H (FH) to control complement activation on the cellular surface. FH binding to endothelial cells (ECs) was also analysed in order to assess possible dysfunctions of this protein.<h4>Principal findings</h4>Fourteen differentially expressed proteins were identified. We detected pneumococcal antibody cross-reacting with double stranded DNA in serum of all bone marrow transplanted patients with ScGVHD. We documented higher levels of FH in serum of SSc and ScGVHD patients compared healthy controls and increased sheep erythrocytes lysis after incubation with serum of diffuse SSc patients. In addition, we observed that FH binding to ECs was reduced when we used serum from these patients.<h4>Conclusions</h4>The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state. We also found a defective function of Factor H, possibly associated with ECs damage.Cinzia ScambiValentina La VerdeLucia De FranceschiGiovanni BarausseFabio PoliFabio BenedettiMarco SorioFrancesca DeriuPaola RoncadaOscar BortolamiFrancesco TurriniPaola CaramaschiChiara StranieriLisa M BambaraDomenico BiasiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 8, p e12162 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cinzia Scambi
Valentina La Verde
Lucia De Franceschi
Giovanni Barausse
Fabio Poli
Fabio Benedetti
Marco Sorio
Francesca Deriu
Paola Roncada
Oscar Bortolami
Francesco Turrini
Paola Caramaschi
Chiara Stranieri
Lisa M Bambara
Domenico Biasi
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
description <h4>Background</h4>Systemic sclerosis (SSc) is an autoimmune disease characterized by immunological and vascular abnormalities. Until now, the cause of SSc remains unclear. Sclerodermatous graft-versus-host disease (ScGVHD) is one of the most severe complications following bone marrow transplantation (BMT) for haematological disorders. Since the first cases, the similarity of ScGVHD to SSc has been reported. However, both diseases could have different etiopathogeneses. The objective of this study was to identify new serum biomarkers involved in SSc and ScGVHD.<h4>Methodology</h4>Serum was obtained from patients with SSc and ScGVHD, patients without ScGVHD who received BMT for haematological disorders and healthy controls. Bi-dimensional electrophoresis (2D) was carried out to generate maps of serum proteins from patients and controls. The 2D maps underwent image analysis and differently expressed proteins were identified. Immuno-blot analysis and ELISA assay were used to validate the proteomic data. Hemolytic assay with sheep erythrocytes was performed to evaluate the capacity of Factor H (FH) to control complement activation on the cellular surface. FH binding to endothelial cells (ECs) was also analysed in order to assess possible dysfunctions of this protein.<h4>Principal findings</h4>Fourteen differentially expressed proteins were identified. We detected pneumococcal antibody cross-reacting with double stranded DNA in serum of all bone marrow transplanted patients with ScGVHD. We documented higher levels of FH in serum of SSc and ScGVHD patients compared healthy controls and increased sheep erythrocytes lysis after incubation with serum of diffuse SSc patients. In addition, we observed that FH binding to ECs was reduced when we used serum from these patients.<h4>Conclusions</h4>The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state. We also found a defective function of Factor H, possibly associated with ECs damage.
format article
author Cinzia Scambi
Valentina La Verde
Lucia De Franceschi
Giovanni Barausse
Fabio Poli
Fabio Benedetti
Marco Sorio
Francesca Deriu
Paola Roncada
Oscar Bortolami
Francesco Turrini
Paola Caramaschi
Chiara Stranieri
Lisa M Bambara
Domenico Biasi
author_facet Cinzia Scambi
Valentina La Verde
Lucia De Franceschi
Giovanni Barausse
Fabio Poli
Fabio Benedetti
Marco Sorio
Francesca Deriu
Paola Roncada
Oscar Bortolami
Francesco Turrini
Paola Caramaschi
Chiara Stranieri
Lisa M Bambara
Domenico Biasi
author_sort Cinzia Scambi
title Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
title_short Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
title_full Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
title_fullStr Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
title_full_unstemmed Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.
title_sort comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous gvhd. evidence of defective function of factor h.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/0f29c7cea65a4325a1a0a80bc85bd6ec
work_keys_str_mv AT cinziascambi comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT valentinalaverde comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT luciadefranceschi comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT giovannibarausse comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT fabiopoli comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT fabiobenedetti comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT marcosorio comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT francescaderiu comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT paolaroncada comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT oscarbortolami comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT francescoturrini comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT paolacaramaschi comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT chiarastranieri comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT lisambambara comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
AT domenicobiasi comparativeproteomicanalysisofserumfrompatientswithsystemicsclerosisandsclerodermatousgvhdevidenceofdefectivefunctionoffactorh
_version_ 1718424397040058368